Cargando…

Prediction of early recurrence and response to adjuvant Sorafenib for hepatocellular carcinoma after resection

BACKGROUND: Early recurrence of hepatocellular carcinoma (HCC) is a major obstacle to improving the prognosis, and no widely accepted adjuvant therapy guideline for patients post-liver resection is available. Currently, all available methods and biomarkers are insufficient to accurately predict post...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zheng, Liming, Gu, Xi, Zheng, Guojun, Li, Xin, He, Meifang, Liu, Longgen, Zhou, Xike
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	PeerJ Inc. 2021
Materias:	Bioinformatics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8628622/ https://www.ncbi.nlm.nih.gov/pubmed/34900444 http://dx.doi.org/10.7717/peerj.12554

Ejemplares similares

Construction and validation of a predictive model for hepatocellular carcinoma based on serum markers
por: Zheng, Liming, et al.
Publicado: (2022)

Transcriptome analysis revealed key prognostic genes and microRNAs in hepatocellular carcinoma
por: Ma, Xi, et al.
Publicado: (2020)

Identification of hepatocellular carcinoma prognostic markers based on 10-immune gene signature
por: Zhao, Kaifei, et al.
Publicado: (2020)

A genomic-clinical nomogram predicting recurrence-free survival for patients diagnosed with hepatocellular carcinoma
por: Kong, Junjie, et al.
Publicado: (2019)

Bioinformatics analysis of tumor-educated platelet microRNAs in patients with hepatocellular carcinoma
por: Zhu, Beibei, et al.
Publicado: (2021)

A glycolysis-related gene pairs signature predicts prognosis in patients with hepatocellular carcinoma
por: Zhou, Weige, et al.
Publicado: (2020)

Association Between Adjuvant Sorafenib and the Prognosis of Patients With Hepatocellular Carcinoma at a High Risk of Recurrence After Radical Resection
por: Li, Qingli, et al.
Publicado: (2021)

Identification of key miRNAs in the progression of hepatocellular carcinoma using an integrated bioinformatics approach
por: Zheng, Qi, et al.
Publicado: (2020)

A meta-analysis of the efficacy and safety of adjuvant sorafenib for hepatocellular carcinoma after resection
por: Huang, Shenglan, et al.
Publicado: (2021)

Integrated bioinformatics analysis revealed the regulation of angiogenesis by tumor cells in hepatocellular carcinoma
por: Huo, Meisi, et al.
Publicado: (2021)

Centromere protein N may be a novel malignant prognostic biomarker for hepatocellular carcinoma
por: Wang, Qingqing, et al.
Publicado: (2021)

Adjuvant Sorafenib Following Radiofrequency Ablation for Early-Stage Recurrent Hepatocellular Carcinoma With Microvascular Invasion at the Initial Hepatectomy
por: Wei, Meng-Chao, et al.
Publicado: (2022)

Construction and analysis of macrophage infiltration related circRNA-miRNA-mRNA regulatory networks in hepatocellular carcinoma
por: Chen, Yuhan, et al.
Publicado: (2020)

CELSR3 mRNA expression is increased in hepatocellular carcinoma and indicates poor prognosis
por: Gu, Xuefeng, et al.
Publicado: (2019)

Active ingredients and molecular targets of Taraxacum mongolicum against hepatocellular carcinoma: network pharmacology, molecular docking, and molecular dynamics simulation analysis
por: Zheng, Yanfeng, et al.
Publicado: (2022)

Identification and validation of ADME genes as prognosis and therapy markers for hepatocellular carcinoma patients
por: Wang, Jukun, et al.
Publicado: (2021)

Autophagy-related genes prognosis signature as potential predictive markers for immunotherapy in hepatocellular carcinoma
por: Mao, Deli, et al.
Publicado: (2020)

Comprehensive profiling of the TRIpartite motif family to identify pivot genes in hepatocellular carcinoma
por: Wu, Lingyun, et al.
Publicado: (2022)

Expression of IER3 in hepatocellular carcinoma: clinicopathology, prognosis, and potential regulatory pathways
por: He, Fei-Yan, et al.
Publicado: (2022)

Prognostic implications of cell division cycle protein 45 expression in hepatocellular carcinoma
por: Yang, Chen, et al.
Publicado: (2021)

Transcriptome changes in ERGIC3-knockdown hepatocellular carcinoma cells: ERGIC3 is a novel immune function related gene
por: Liu, Mengyuan, et al.
Publicado: (2022)

DUSP12 regulates the tumorigenesis and prognosis of hepatocellular carcinoma
por: Ju, Gaoda, et al.
Publicado: (2021)

Factors influencing early recurrence of hepatocellular carcinoma after curative resection
por: Zhu, Yu, et al.
Publicado: (2020)

Prognostic value and immune landscapes of immunogenic cell death-related lncRNAs in hepatocellular carcinoma
por: Chen, Wanying, et al.
Publicado: (2023)

From big data to diagnosis and prognosis: gene expression signatures in liver hepatocellular carcinoma
por: Yang, Hong, et al.
Publicado: (2017)

The potential, analysis and prospect of ctDNA sequencing in hepatocellular carcinoma
por: Ding, Yubo, et al.
Publicado: (2022)

A novel fatty acid metabolism-related gene prognostic signature and candidate drugs for patients with hepatocellular carcinoma
por: Yang, Jingze, et al.
Publicado: (2023)

Weighted gene correlation network analysis reveals novel regulatory modules associated with recurrent early pregnancy loss
por: Li, Xiaoxiao, et al.
Publicado: (2020)

Identification of prognostic and metastasis-related alternative splicing signatures in hepatocellular carcinoma
por: Huang, Runzhi, et al.
Publicado: (2020)

Diagnostic and prognostic values of upregulated SPC25 in patients with hepatocellular carcinoma
por: Yang, Xiaolin, et al.
Publicado: (2020)

Development and validation of ferroptosis-related lncRNAs signature for hepatocellular carcinoma
por: Liang, Jiaying, et al.
Publicado: (2021)

Upregulated TUBG1 expression is correlated with poor prognosis in hepatocellular carcinoma
por: Zhang, Kainan, et al.
Publicado: (2022)

Liver Resection after Downstaging Hepatocellular Carcinoma with Sorafenib
por: Barbier, L., et al.
Publicado: (2011)

Cell division cycle associated 2 (CDCA2) upregulation promotes the progression of hepatocellular carcinoma in a p53-dependant manner
por: Wang, Jiahui, et al.
Publicado: (2022)

Identification of crucial genes based on expression profiles of hepatocellular carcinomas by bioinformatics analysis
por: Liu, Ze-Kun, et al.
Publicado: (2019)

Identification of four prognostic LncRNAs for survival prediction of patients with hepatocellular carcinoma
por: Wang, Zhonghao, et al.
Publicado: (2017)

Identification of a prognostic signature of nine metabolism-related genes for hepatocellular carcinoma
por: Tang, Chaozhi, et al.
Publicado: (2020)

DPM1 expression as a potential prognostic tumor marker in hepatocellular carcinoma
por: Li, Ming, et al.
Publicado: (2020)

Bioinformatics profiling identifies seven immune-related risk signatures for hepatocellular carcinoma
por: Xue, Feng, et al.
Publicado: (2020)

Comprehensive analysis reveals a metabolic ten-gene signature in hepatocellular carcinoma
por: Zhu, Zhipeng, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_qli2ff82onuugh13peag1t66e5